Symposium on “Medical cannabis in Europe: current trends and the state of the art”

Hamburg, Germany, June 19-20, 2025

Organisation:

* TIS Research, Hamburg, Germany

* World Research Programme on Medical Cannabis under the

Research and Transfer Centre Sustainable Development and Climate Change Management, Hamburg University of Applied Sciences, Germany

Rationale

The European medical cannabis market reached a value of US$ 2,167.8 million in 2023. The market is expected to reach US$11,093.7 million by 2032, exhibiting a growth rate (CAGR) of 19.3% between 2024 and 2032. As medical cannabis is being legalised in several European countries, it is necessary to understand the regulatory frameworks, guidelines and compliance requirements. In addition, with the increased use of medical cannabis, there is a need for robust research and clinical data to assess its efficacy, safety and therapeutic potential in different conditions.

There is also a need to educate healthcare professionals, patients and the general public about the possible benefits and risks associated with the use of medical cannabis. The evolving scenario requires the involvement of various stakeholders. This includes, on the one hand, the companies that produce and sell medical cannabis and, on the other hand, policymakers, healthcare providers, researchers, and patient advocates to share perspectives and collaborate on best practices.

It is in this context, and based on the perceived need to provide a platform for a broader discussion on medical cannabis, that the Symposium “Medical cannabis in Europe: an assessment of trends and the state of the art” is being organised.

Objectives of the Symposium

To analyse and present current trends in the use of medicinal cannabis in Europe, including changes in legislation, market growth and patient demographics.
To present and discuss recent scientific studies and clinical trials related to medical cannabis, creating a comprehensive overview of current knowledge and research gaps.
To create a platform for dialogue between companies in the field, fostering partnerships that can drive future research, advocacy and policy initiatives.
To share best practices from different countries and regions, allowing participants to learn from each other's experiences and implement effective strategies in their own contexts.
To contribute to a better understanding of the commercialisation of medical cannabis, encourage responsible use and ultimately improve patient care across Europe.

Topics

Overview of the medical cannabis market in Europe
Industry and market trends
Legal frameworks for production: Cannabis legislation in European countries
Innovations in cultivation, production and distribution
Quality control and safety standards for medical cannabis
Legislation on medicinal use and regulatory approaches
Case studies from specific countries (e.g. Germany, Portugal, Spain, UK)
Medical research and evidence (e.g. pain management, neurological disorders,cancer treatment)
Benefits and risks of medical cannabis
Impacts on patient care and treatment options
Role of healthcare professionals in prescribing cannabis
Patient perspectives
Importance of patient education and support

Other topics may be discussed; please contact the organisers to discuss them.

Target audience

Companies and entrepreneurs involved in the production, distribution and sale of medicinal cannabis products.
Investors wishing to enter or expand in the medical cannabis market.
Healthcare professionals: doctors, nurses and pharmacists interested in understanding the therapeutic applications, dosage and possible side effects of medical cannabis, as well as specialists in pain management, oncology, neurology and other relevant fields.
Scientists conducting clinical trials or studies related to medical cannabis, cannabinoids and their effects on various health conditions.
Policymakers and government representatives involved in the regulation and legislation of medical cannabis at the national and EU levels.
Representatives of health agencies and regulatory bodies.
Organisations representing patients who use or are interested in using medical cannabis for various health problems.
Lawyers and legal experts specializing in regulatory compliance, commercial law and intellectual property in relation to the cannabis sector.
Professionals focused on the public health implications of medical cannabis use, including its impact on education and health promotion.

How to attend the Symposium

There are two possibilities for attending the symposium:

1. By only attending the Symposium: Please register through the form bellow.

2. By attending the symposium and making a presentation: Those who want to make a presentation need to submit an abstract of 200 to 300 words, along with the authors' names and full contact details before 30 April 2025. Abstracts should be submitted through this form.

Registration Fees

In other to offset the preparation and running costs, a registration fee of Euro 375,00 (plus taxes) will be charged per delegate. The fees entail the coffee breaks and lunch breaks during the 2 days.

For cancellations made up to 1 month before the event, a full refund -minus handling charges- will be possible. For cancellations within less than 30 days, no refunds are possible. The details about the payment will be sent to the participants.

Contact and further details

For any inquiries, please feel free to contact us at the following address:

TIS Research

Neuer Wall 80, 20354 Hamburg, Germany
E-mail: contact(at)tis-research(dot)eu